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Abstract
We have previously demonstrated that relatively high concentrations of NO [Nitric Oxide] as produced by activated
macrophages induced apoptosis in the human breast cancer cell line, MDA-MB-468. More recently, we also demonstrated
the importance of endogenous H2O2 in the regulation of growth in human breast cancer cells. In the present study we
assessed the interplay between exogenously administered NO and the endogenously produced reactive oxygen species
[ROS] in human breast cancer cells and evaluated the mechanism[s] in the induction of apoptosis. To this end we identified
a novel mechanism by which NO down regulated endogenous hydrogen peroxide [H2O2] formation via the down-
regulation of superoxide [O2
.2] and the activation of catalase. We further demonstrated the existence of a feed forward
mechanistic loop involving protein phosphatase 2A [PP2A] and its downstream substrate FOXO1 in the induction of
apoptosis and the synthesis of catalase. We utilized gene silencing of PP2A, FOXO1 and catalase to assess their relative
importance and key roles in NO mediated apoptosis. This study provides the potential for a therapeutic approach in treating
breast cancer by targeted delivery of NO where NO donors and activators of downstream players could initiate a self
sustaining apoptotic cascade in breast cancer cells.
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Introduction
We have previously demonstrated that relatively high concen-
trations of NO [1 mM DETA-NONOate also referred to as
DETA], as released from activated macrophages, induced
apoptosis in MDA-MB-468 human breast cancer [HBC] cells by
caspase-3 activation [1].These effects were found to be cyclic
GMP [cGMP] independent [1].This prompted us to investigate
the cGMP independent mechanism[s] of NO action in the
apoptosis of HBC cells. In a subsequent and a more recent
publication we have also demonstrated that HBC cells strategically
maintained significantly higher endogenous levels of H2O2
compared to normal human breast epithelial [HBE] cells [2].
This was due to the increased production of O2
.2 by HBC cells
thereby inhibiting the enzyme activity of catalase resulting in
increased intracellular H2O2 levels [2]. This was evidenced by the
elevation of catalase activity in HBC cells following treatment with
pegylated superoxide dismutase [PEG-SOD] [2]. Following
silencing of catalase activity, there was further increase in H2O2
levels and this induced HBC growth via the inactivation of PP2A
activity [2]. Conversely the reduction of H2O2 levels in HBC cells
following overexpression of catalase, was associated with increased
PP2A activity leading to apoptosis [2].
In this study we have demonstrated that one of the cellular
mechanisms by which NO induced apoptosis in HBC cells was by
decreasing the endogenous levels of H2O2. NO mediated decrease
in H2O2 levels was associated with both, decreased levels of O2
.2
[a direct precursor of H2O2], as well as by the induction of the
transcription of catalase [an enzyme which metabolizes H2O2].
We also observed that protein phosphatase 2A [PP2A], and one of
its down stream substrates, FOXO1 [a member of the Fork Head
Family of transcription factors], played an important role in NO
mediated apoptosis. PP2A, an important serine/threonine phos-
phatase, has been reported to be involved in the regulation of cell
homeostasis, through the negative regulation of signaling pathways
initiated by kinases [3]. Furthermore, PP2A has been shown to
increase the expression of pro-apoptotic proteins such as BIM, and
BAX [4]. We have previously reported that reduction of H2O2
levels [by the overexpression of catalase] could activate PP2A in
HBC cells [2]. On this basis we hypothesized that NO may
activate PP2A activity via the lowering of H2O2 levels thereby
leading to apoptosis. FOXO1, which has also been reported to
induce the synthesis of pro-apoptotic proteins such as BIM and
BAX [5], has been shown to be activated by PP2A [5].
Interestingly, we have previously reported that the pro-apoptotic
protein BAX, played an important role in the induction of NO
mediated apoptosis in MDA-MB-468, HBC cells [1]. We therefore
extended our hypothesis to include FOXO1 as an intermediate in
the mechanism of NO mediated apoptosis in MDA-MB-468 cells.
In summary, the findings from this study helped identify
another novel mechanism by which NO, by modulating endog-
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enous levels of H2O2 induced apoptosis in HBC cells. The results
from this study also underlined the important role of the PP2A-
FOXO1 signaling cascade in NO mediated apoptosis.
Materials and Methods
Materials
Protease Inhibitor Cocktail [P8430], Catalase-polyethylene
glycol [PEG-CAT] [C4963], Superoxide Dismutase-polyethylene
glycol [PEG-SOD] [S9549], 3% H2O2 [#323381], MnTBAP[M-
n[III] tetrakis [4-Benzoic acid] porphyrin chloride] 98% pure, was
purchased from Calbiochem, SanDiego, CA,. PMSF [P-7626] and
all other chemicals including dithiothreitol [DTT], were pur-
chased from Sigma [St. Louis, MO] unless stated otherwise.
Hydroethidium [HE] [D11347] was purchased from Molecular
Probes [Eugene, OR]. Amplex Red, H2O2 assay kit # A22188
was purchased from Life Technologies, Carlsbad, CA. The
following primary antibodies were used: Catalase [C0979] [Sigma,
St. Louis, MO]; PP2A-Ca [sc-130237] and GAPDH [sc-166545]
from Santa Cruz Biotechnology, Santa Cruz, CA, Antibodies
against FOXO1 [#2880] and pFOXO1[ serine 256][#9461]
were obtained from Cell signaling, Danvers, MA. Nitrated BSA
[control for nitro tyrosine detection], was obtained from Cayman
Chemicals # 89542, Ann Arbor MI. Human breast tissues,
normal and from patients with adenocarcinoma were obtained
from the translational pathology core laboratory at UCLA, Los
Angeles in accordance with university guide lines.
Methods
Cell Culture. Human breast cancer cell lines MDA-MB-468
[ER-VE] [passage no 355] and MDA-MB-231 [ER-VE] [passage
No. 350] and MCF-7 [ER+VE] [passage No. 67] were obtained
from American Type Culture Collection [Manassas, VA].
DMEM, 16 was purchased from Mediatech [Manassas, VA]
[Cat. No. 10-017-CV]. MDA-MB-468 and MDA-MB-231 were
grown in DMEM supplemented with 10 mM nonessential amino
acids, 2 mM L-glutamine, 1 mg/mL insulin, and 5% fetal bovine
serum [FBS]. MCF-7 cells were grown in DMEM supplemented
with 10 mM nonessential amino acids, 2 mM L-glutamine, 1 mg/
mL insulin, and 5% fetal bovine serum [FBS]. Treatment with
DETA-NONOate 1 mM or heat-inactivated controls were done
in the presence of serum for 24 h unless specified. Pegylated
catalase or pegylated superoxide dismutase treatments were also
performed for 24 h for relevant experiments. Following treatment
cells were harvested utilizing trypsin and processed for down
stream assays. Cells were passaged no more than 10 times after
being procured from the company and their genetic characteristics
were tested regularly. We regularly checked for the presence of
mycoplasma with Lonza’s MycoAlert mycoplasma detection kit
[LT07-318]. For experimental purposes, cells were allowed to seed
overnight prior to all treatments. All treatments were done under
serum-free conditions unless otherwise noted.
Superoxide detection. Superoxide was determined as de-
scribed by Zeolonka et.al, [6] which quantifies 2-OH-Ethidium [a
specific product of Hydroethidium [HE] and O2
.2] following its
separation from other oxidized products of HE by HPLC. Values
were normalized against total protein. Briefly 10 mM HE was
added in cell culture for 20 m at 37uC. This was followed by lysing
in a 0.25-mL lysis buffer [DPBS with 0.1% Triton X-100,
pH 7.4], and cell protein levels were measured. A 10-ml lysis
solution was used for measuring protein concentration. The
remaining solution was mixed with 0.5 mL of 1-butanol, vortex-
mixed for 1 min, and centrifuged. The butanol phase was
separated and dried with nitrogen. Dried samples were taken up
into the solution by adding 0.1 mL of water for HPLC analysis.
The cell number was normalized to protein levels in cell lysates,
and HPLC peak areas in individual experiments were normalized
to the protein concentration.
Hydrogen peroxide detection. The rate of H2O2 produc-
tion was determined using the Amplex Red Hydrogen Peroxide
Assay Kit [Invitrogen, A22188] as per the manufacturer’s protocol
and as described earlier by Sen et. al [2]. Briefly 50,000 cells were
added to 100 ml of an enzyme assay buffer [50 mM potassium
phosphate buffer, pH 7.4] containing 0.1 U/mL of horse radish
peroxidase [HRP] and 50 mM of Amplex Red. The conversion of
Amplex Red to resorufin [Ex/Em: 570/585 nm] was measured
over time. The maximum fluorescence intensity was achieved at
4–6 hours after exposure to the Amplex Red reagent.
PP2A assay. PP2A activity was assayed using the PP2A
Immunoprecipitation Assay Kit [Millipore, 17-313] as per the
manufacturer’s protocol. Cells [56106] were scraped from dishes
with 0.3 mL phosphate extraction buffer [20 mM imidazole-HCl,
2 mM EDTA, 2 mM EGTA, pH 7.0, with 10 mg/mL each of
aprotinin, leupeptin, antipain, soybean trypsin inhibitor, 1 mM
benzamidine and 1 mM PMSF. Cells were sonicated for ten
seconds, then centrifuged at 20006 g for 5 minutes. After
immunoprecipitation of the cellular lysate for PP2A, the enzymatic
activity of PP2A was determined by the dephosphorylation of the
substrate K-R-pT-I-R-R and the coordination of the resulting free
phosphate with Malachite Green. Activity levels were normalized
to the amount of PP2A immunoprecipitated purified as deter-
mined by SDS-PAGE and Western analysis as previously
described. The specific PP2A activities were compared between
cell lines and reported as fold-differences. Tissue lysates for PP2A
assay were prepared in PP2A assay buffer in the presence of
protease cocktail inhibitors using a hand held tissue homogenizer.
Extracts were clarified by centrifugation at 12000 g for 30 m just
before assaying. Tissues were obtained from the UCLA pathology
core facilities which operate within the frame work of UCLA
certified protocols to obtain human samples. We did not access
any patient information.
Western blotting. Cytoplasmic extracts were prepared from
cells after various treatments by lysis in buffer containing
50 mm HEPES [pH 7.5], 1 mm DTT, 150 mm NaCl, 1 mm
EDTA, 0.1% Tween 20, 10% glycerol, 10 mm b-glycerophos-
phate, 1 mm NaF, 0.1 mm orthovanadate, 10 mg/ml leupeptin,
10 mg/ml aprotinin, and 0.1 mm phenylmethylsulfonyl fluoride
and kept at 4uC for 30 min. cytosolic protein concentrations
were quantified by Bradford assay. Equal amounts [20 mgs of
protein] were separated on a 10% SDS-PAGE gel and
transferred onto polyvinylidene difluoride membranes. Incuba-
tion with primary and horse radish peroxidase conjugated
secondary antibodies were done at 4uC overnight and 1 h at
RT, in 1: 1000 and 1: 10,000 dilutions respectively. Immuno-
reactivity was detected by using enhanced chemiluminescence
[Amersham Biosciences].
Detection of apoptosis by flow cytometry. Flow cytometry
experiments assaying apoptosis/necrosis were determined with
apoptosis/necrosis detection kits containing Annexin V-FITC [BD
Pharmingen, 51-6710AK]. Briefly, 16106 cells were washed twice
with cold, 16 PBS and resuspended in 100 ml of 16 Binding
Buffer. The cells were transferred to 5-mL culture tubes and
stained with 5 ml Annexin V-[Cy3/FITC] and 5 ml of 7-AAD/
propidium iodide respectively, as per respective manufacturer’s
protocol. The cells were incubated for 15 min at room temper-
ature in the dark. 400 ml additional 16Binding Buffer was added
to the samples and the cells were analyzed with a BD FACScan
software from Becton Dickinson [Franklin Lakes, NJ]. Apoptotic
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cells showed an increased staining with Annexin V–FITC
wherever applicable.
Caspase-3 assay. Control and treated cells were lysed in
insect cell lysis buffer [50 mM 4-[2-hydroxyethyl]-1-piperazi-
neethanesulfonic acid, 100 mM NaCl, 2 mM EDTA, 0.1% 3-
[[3-cholamidopropyl] dimethylammonio]-1-propanesulfonic acid,
10% sucrose, 5 mM DTT, and 16protease inhibitor cocktail] for
30 min at 4uC. The lysates were incubated in assay buffer with
20 mg of caspase-3 substrate [acetyl-Asp-Glu-Val-Asp-amino-
methylcoumarin] obtained from BD Pharmigen [Franklin Lakes,
NJ]. Active caspase-3 activity was monitored by production of
fluorescent AMC [Ex/Em: 380/440 nm], which was quantified
using a VersaFluor fluorometer from Bio-Rad [Hercules, CA] and
operated as per the manufacturer’s protocol.
Catalase Assay. Catalase assay was performed according to
the methods of Beers et.al [7]. Briefly 100 mgs of cell extract was
prepared in phosphate buffer pH 7.0 and mixed with 1 mMH2O2
at 37uC in a quartz cuvette and the disappearance of H2O2 was
measured over time at 240 nm. Results were normalized as
difference in final versus initial absorbance per unit time per unit
mgs of protein extract.
Quantitative PCR. Total RNA from cells was purified using
TRIzol reagent [Invitrogen] according to the manufacturer’s
protocol, and cDNA was synthesized with oligo[dT] primers using
SuperScript III [Invitrogen]. Real-time RT-PCR analysis was
carried out with iQ SYBR Green supermix [Bio-Rad] on an
iCycler iQ real-time PCR detection system for forty cycles [Bio-
Rad]. b-actin [human] was used as an internal control to calculate
the relative expression. Primer pairs were obtained from Qiagen
for human b-actin [PPH000420b-200], human catalase
[PPH00420B-200], and human FOXO1 [PPH01964F-200], and
from Santa Cruz Biotechnology for the catalytic subunit of human
PP2A [sc-43509-PR]. In each case, relative mRNA expression
values [Target mRNA vs b-actin] were calculated using the
22[DDCt] method.
Gene silencing utilizing siRNA. SiRNAs againt the PP2A
catalytic subunit [NM _002715] and FOXO1 [NM_002015.3]
were obtained from Santa Cruz biotech, PP2A Ca siRNA [Sc-
43509] and FOXO1siRNA [Sc-35383] respectively were obtained
from Santa Cruz Biotech Non-specific, scrambled siRNA from the
same company were used as a control. siRNA against human
catalase was also obtained from Santa Cruz biotech # Sc 45330.
Briefly 26105 cells were seeded in a 6-well plate one day prior to
transfection. For each well, the siRNA stock was diluted in the
appropriate amount of Opti-MEM I reduced serum medium and
the cells were transfected with LipofectAMINETM 2000 Invitrogen,
CA, USA], according to the manufacturer’s instructions. Cells were
incubated at 37uC in a CO2 incubator for 24–72 h and the effect of
gene silencing was analysed by immunoblots. Appropriate cell
lysates from Santa Cruz Biotech, Sc-80665, and Sc-2221 were used
as controls for western blots for PP2Aand FOXO1 respectively.
Statistics. All values are expressed as mean 6 SE. Each
value is the mean of at least three separate experiments in each
group. The differences in the effects of drug treatment when
compared with control values were analyzed by students T test. P
values equal to or less than 0.05 were considered significant,
**,p.005 *,p.05.
Results
DETA treatment modulated the ROS status in MDA-MB-
468 cells
DETA [1 mM], reduced the endogenous superoxide [O2
.2]
levels in MDA-MB-468 cells associated with increased formation
of nitrated tyrosine species, which was partially reversible upon
pre-incubation with MnTBAP [Fig. 1a & b]. PEG-SOD treatment
was used as a control to validate the assay system. 500 U/mL of
PEG-SOD or vehicle control [ 0.1% DMSO] was added to cell
cultures for 24 h before assaying for O2
.2 production. This was
also accompanied by a decrease in the H2O2 production over time
[Fig. 1c]. Pegylated catalase [PEG-CAT] treatment was used as a
control to validate the assay system. 100 U/mL of PEG-CAT or
vehicle controls [ 0.1% DMSO] were added to cell cultures for
24 h before assaying for H2O2 production.[Fig. 1d]. Exposure of
MDA-MB-468 cells to heat inactivated DETA ie DETA kept at
37uC for 7 days as validated earlier [1] did not affect the
endogenous H2O2 levels confirming that the observed events were
specific to the modulations of NO. Two other breast cancer cell
lines, MDA-MB-231 [Estrogen receptor –ive] and MCF7 [Estro-
gen receptor +ive] also exhibited a decrease in the endogenous
levels of H2O2 at 24 h following exposure to 1 mM DETA [1f].
Important role of PP2A in NO induced apoptosis
A recent publication from our lab elaborated the inverse
correlation between endogenous H2O2 levels and PP2A activity in
breast cancer models [2]. Interestingly following exposure to
1 mM DETA, both MDA-MB-468 and MCF7 breast cancer cells
exhibited an increase in PP2A activity. [Fig. 2a, left and right
panels respectively]. As PP2A activity has been reported to be
associated with increased apoptotic tendency in HBC cells [2], we
assessed its role in NO mediated apoptosis. An attenuation in the
increase of Annexin V binding and caspase 23 activity was
observed upon DETA-NONOate treatment on MDA-MB-468
cells silenced for the catalytic subunit of PP2A [Fig. 2b–2d]. There
was a modest increase in Annexin V binding upon PP2A silencing
which may be attributed to cell proliferative properties of PP2A
[19].
Important role of FOXO1 in NO induced apoptosis
FOXO1, an important pro-apoptotic transcription factor has
been reported to be a substrate for PP2A [4]. We assessed the role
of PP2A-FOXO1 interplay in NO mediated apoptosis in breast
cancer. Interestingly it was observed that NO treatment induced
the dephosphorylation of pFOXO1 in MDA-MB-468 as well as in
MCF7 cells. [Fig. 3a, left and right panels], and prior silencing of
PP2A attenuated the dephosphorylation event as exhibited in
MDA-MB-468 cells. [Fig. 3b]. Increased nuclear concentration of
FOXO was observed at 4 h following DETA treatment in MDA-
MB-468 cells [Fig. 3c]. Significant dephosphorylation of pFOXO1
was first observed between 2–6 h [Fig. 3a]. Interestingly significant
FOXO accumulation was observed at 4 h [between 2 and 6 h ]
following DETA treatment. This is in agreement with the
established observation that FOXO translocates to the nucleus
following dephosphorylation. Furthermore it was observed that
DETA treatment on cells silenced for FOXO1 exhibited
decreased Annexin V binding and caspase -3 activity compared
with scrambled controls [Fig. 3d–f]. Interestingly siFOXO
exhibited increased Annexin V binding compared to siScram-
ble. This could be attributed to the activation of some of its
isoforms such as FOXO3 as a compensatory mechanism in
response to FOXO1 silencing. Indeed FOXO3 has been
observed in breast cancer and does play a role in apoptosis
[20]. A modest increase in Annexin V binding in siFOXO
following DETA treatment suggests the existence of alternative
pathways independent of FOXO1 in NO mediated apoptosis.
Thus the PP2A-FOXO1 axis is an important pathway but
certainly not the only one.
Induction of a Pro-Apoptotic Mechanistic Loop
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Important role of catalase in NO induced apoptosis
Several reports have described the induction of antioxidant
gene expressions [including catalase], upon activation of
FOXO1 [8]. Moreover we have shown earlier, that overex-
pression of catalase led to apoptosis [2]. We therefore
investigated the role of catalase in NO mediated apoptosis.
Interestingly we observed that, DETA [1 mM] increased the
mRNA as well as protein expression of catalase associated with
an increase in its enzyme activity [Fig. 4a–c, left panel]. Increase
in catalase bioactivity, following DETA treatment was also
Figure 1. Fold changes in O2
.2 levels in MDA-MB-468 upon treatment with 1 mM DETA-NONOate over 24 h [a]. Western blot
analysis of MDA-MB-468 cell lysate using anti-3-nitrotyrosine antibody at 24 h following treatment with 1 mM DETA-NONOate,
with or without prior treatment with 10 mM MnTBAB [b]. Rate of H2O2 production as measured by Amplex Red in MDA-MB-468 cells with or
without the treatment with 1 mM DETA-NONOate [c]. H2O2 production determined in MDA-MB-468 cells with or without the treatment of pegylated-
catalase [100 U/mL] at 8 h [d]. H2O2 production determined in MDA-MB-468 cells with or without inactivated DETA [e]. H2O2 production determined
in MDA-MB-231 and MCF-7 upon treatment with 1 mM DETA-NONOate at 24 hours [f]. Results are expressed as the means from three independent
experiments performed in duplicate; bars, SE wherever applicable. Western blot images are representative of three different experiments. GAPDH is
probed as an equal loading control wherever applicable.
doi:10.1371/journal.pone.0070593.g001
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Figure 2. PP2A activity in cell lysates of MDA-MB-468 cells at 24 h following treatment with or without 1 mM DETA-NONOate [a,
left panel] PP2A activity in cell lysates of MCF-7 at 24 h following treatment with or without imM DETA-NONOate [a, right panel].
Silencing of the catalytic subunit of human PP2A utilizing siRNA depicted by immunoblotting [b, left panel]. Silencing of the catalytic subunit of
human PP2A utilizing siRNA depicted by qPCR [b right panel]. Annexin V binding assay at 24 h, in MDA-MB-468 cells either transfected with
scrambled controls [siScramble] or siRNA against the human PP2A gene [siPP2A] [c]. Caspase-3 activity in MDA-MB-468 at 24 h following treatment
with 1 mM DETA-NONOate in either scrambled controls [siScramble] or silenced for the catalytic subunit of PP2A [siPP2A] following treatment with
1 mM DETA-NONOate [1 mM DETA] [d]. PP2A activity in two tissue samples from either normal breast or those from patient tumors: denoted by N1,
N2, and T1,T2 respectively [e]. Results are expressed as the means from three independent experiments performed in duplicate; bars, SE wherever
applicable. Western blot images are representative of three different experiments. GAPDH is probed as an equal loading control wherever applicable.
doi:10.1371/journal.pone.0070593.g002
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observed in another breast cancer cell line, MCF7 [Fig. 4c right
panel]. Investigation of the critical role of catalase in NO
mediated apoptosis utilizing siRNA mediated gene silencing
revealed: [1] Attenuation in the decrease in endogenous H2O2
levels following DETA treatment [Fig. 4e] [2] Attenuation in
the increase of Annexin V binding upon DETA treatment [
Fig. 4 f] [3] Attenuation in the decrease in caspase- 3 activity
following DETA treatment [Fig. 4g–h].
Important role of the PP2A and FOXO1 in the induction
of catalase gene expression
Investigating the role of PP2A and FOXO1 in the induction of
catalase revealed attenuation in the increase of catalase mRNA
and protein expression, upon DETA treatment in either PP2A or
FOXO1 silenced MDA-MB-468 cells [Fig. 5 a and b]. Interest-
ingly overexpression of catalase [MDAOXCAT] led to the
dephosphorylation of pFOXO1 compared to empty vector
Figure 3. Immunoblot analysis of the dephosphorylation of pFOXO1 at serine 256, in MDA-MB-468 cell lysates, over time following
treatment with 1 mM DETA-NONOate [a, left panel]. Immunoblot analysis of the dephosphorylation of pFOXO1 at serine 256 in
MCF-7 cell lysates at 24 h post-treatment with 1 mM DETA-NONOate [a right panel]. Immunoblot analysis of dephosphorylation of
pFOXO1 upon DETA-NONOate treatment in either scrambled controls or MDA-MB-468 cells silenced for the catalytic subunit of PP2A [PP2A siRNA]
[b]. Immunoblot analysis of FOXO1 in MDA-MB-468 nuclear fractions at 24 h post-treatment with 1 mM DETA-NONOate [c ]. Silencing of FOXO1 in
MDA-MB-468 cells utilizing siRNA against human FOXO1 [d left panel] qPCR analysis to determine the fold change in mRNA expression of FOXO1 in
MDA-MB-468 transfected with either scrambled controls [SiScramble] or siRNA against the human FOXO1 gene [siFOXO] [d, right panel]. Annexin V
binding assay at 24 h, in MDA-MB-468 cells either transfected with scrambled controls [siScramble] or siRNA against the human FOXO1 gene,
following treatment with 1 mM DETA-NONOate [1 mM DETA] [e]. Caspase-3 activity in MDA-MB-468 at 24 h following treatment with 1 mM DETA-
NONOate in either scrambled controls [siScramble] or silenced for human FOXO1 gene [siFOXO] [f]. Results are expressed as the means from three
independent experiments performed in duplicate; bars, SE wherever applicable. Western blot images are representative of three different
experiments. GAPDH and Lamin A are probed as equal loading controls for cytosolic and nuclear nuclear fractions respectively.
doi:10.1371/journal.pone.0070593.g003
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controls [Empty Vector] indicating NO initiates a feed forward
mechanistic loop to cause apoptosis in MDA-MB-468 cells
[Fig. 5c]. As expected the dephosphorylation event was inhibited
upon PP2A silencing [Fig. 5d] indicating the dependency of the
phosphorylation process on PP2A activity.
Discussion
In this study we have elucidated a novel mechanism by which
relatively high concentrations of NO [as released from activated
macrophages ie ,0.5 mM NO over 24 h] [18], modulated the
levels of endogenous ROS to induce apoptosis in HBC cells. We
have previously demonstrated that NO, in concentrations [as
released from activated macrophages and mimicked by the
treatment of 1 mM DETA-NONOate], induced apoptosis in
MDA-MB-468 HBC cells [1]. We observed that NO induced a
pro-apoptotic cascade of events involving the activation of MKP1,
a dual specificity phosphatase, which was responsible for the
dephosphorylation of ERK1/2, which in-turn was associated with
the integration of BAX to the inner mitochondrial membrane to
cause apoptosis [1]. More recently we demonstrated the existence
of an endogenous ROS mediated, pro-survival mechanism, which
was constitutively operational in HBC cells. We observed that
HBC cells strategically maintained elevated levels of H2O2 [when
compared to HBE cells], to inhibit PP2A [a serine threonine
phosphatase, also known to inactivate ERK1/2 and AKT], to
elicit continuous growth. In this study we have elucidated that
along with the induction of a pro-apoptotic pathway, NO
Figure 4. qPCR analysis to determine fold change in mRNA expression of catalase in MDA-MB-468 cells at 4 h following treatment
with 1 mM DETA-NONOate [a]. Immnoblot analysis of the expression of catalase in lysates of MDA-MB-468 cells following
treatment with 1 mM DETA-NONOate [b, left panel]. Densitometric analysis of catalase expression utilizing the Image Quant software [b, right
panel]. Enzyme activity of catalase in 100 mg of cell lysate of MDA-MB-468 cells with or without the addition of 1 mM DETA-NONOate [c, left panel]
Enzyme activity of catalase in 100 mg of cell lysate of MCF-7 cells with or without the addition of 1 mM DETA-NONOate [c, right panel]. Silencing of
catalase in MDA-MB-468 cells utilizing siRNA against human catalase depicted by immunobloting and qPCR [d, left and right panel]. H2O2 production
in MDA-MB-468 cells either transfected with scramble controls or siRNA against catalase, at 24 h following treatment with 1 mM DETA-NONOate [e].
Annexin V binding assay at 24 h, in MDA-MB-468 cells either transfected with scrambled controls [siScramble] or siRNA against the human catalase
gene, following treatment with 1 mM DETA-NONOate [1 mM DETA] [f]. Graphical representation of the quantification of cells undergoing apoptosis
in either scramble controls or in catalase silenced MDA-MB-468, following treatment with 1 mM DETA-NONOate [g]. Caspase-3 activity in MDA-MB-
468 at 24 h following treatment with 1 mM DETA-NONOate in either scrambled controls [siScramble] or silenced for human catalase gene [siCAT] [h].
Results are expressed as the means from three independent experiments performed in duplicate; bars, SE wherever applicable. Western blot images
are representative of three different experiments. GAPDH is probed as an equal loading control wherever applicable.
doi:10.1371/journal.pone.0070593.g004
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treatment also initiated an ‘‘anti – growth’’ mechanism in which it
directly interfered with the ROS mediated growth signaling to
supplement the pro-apoptotic pathway.
Our data indicated that NO treatment significantly decreased
H2O2 levels in HBC cells. This was a consequence of both a
reduction in the levels of O2
.2 , a precursor of H2O2 and the
activation of catalase, one its metabolizing enzyme. The decrease
in O2
.2 levels suggested that NO, either inhibited the production
of O2
.2 or directly quenched it . There are reports of NO
inhibiting the assembly of NADPH oxidases to reduce O2
.2
production [9]. This could be a possibility in our model system as
well, as HBC cells have been reported to exhibit increased
expressions of NADPH-oxidases, such as NOX4 [10]. It would
be interesting to investigate the role of NO in the assembly
processes of mitochondrial electron chain complexes which are
seats of O2
.2 generation. As NO can function as a heme ligand
[11], it could be envisaged that it might interfere with the heme
insertion processes during the assembly of key heme proteins
such as cytochrome c oxidase. As far as the direct quenching of
O2
.2 is concerned there could be the possibility of peroxynitrite
Figure 5. qPCR analysis to compare the expression of catalase mRNA in MDA-MB-468 cells transfected with scrambled controls,
siRNA against FOXO1 and SiRNA against PP2A following treatment with 1 mM DETA-NONOate for 4 h [a]. Immunoblot analysis of
catalase protein expression in the lysates of MDA-MB-468 cells transfected with scrambled controls, siRNA against FOXO1 and
siRNA against PP2A at 24 h following treatment with 1 mM DETA-NONOate [b]. Immunoblot analysis of total and pFOXO1 in lysates of
MDA–MB-468 cells at 24 h, following overexpression of either the human catalase gene [MDAOXCAT] or empty vectors in scrambled controls or in
cells silenced for the catalytic subunit of PP2A [c–d]. Results are expressed as the means from three independent experiments performed in duplicate;
bars, SE wherever applicable. Western blot images are representative of three different experiments. GAPDH is probed as an equal loading control
wherever applicable.
doi:10.1371/journal.pone.0070593.g005
Induction of a Pro-Apoptotic Mechanistic Loop
PLOS ONE | www.plosone.org 8 August 2013 | Volume 8 | Issue 8 | e70593
formation as the rate of combination between the reactants has
been reported to be as high as 261010 [12]. Nonetheless,
controversy exists regarding the role of peroxynitrite in various
pathophysiological processes.
Our observation that the formation of nitrated tyrosine species,
was associated with that of O2
.2 reduction , suggested the
involvement of reactive nitrogen species, that caused nitration of
tyrosine residues in proteins. This could most likely be nitrogen
dioxide, as tyrosine nitration is dioxygen dependent [13]. The
exact identification or mechanism of formation of the relevant
nitrogen species remained to be investigated. Our observation that
the formation of nitrated tyrosine species was partially reversible
by MnTBAP may suggest the intermittent formation of peroxyni-
trite [as there have been reports describing MnTBAP to be a
specific quencher of peroxynitrite [14], or MnTBAP could simply
have acted as a superoxide dismutase mimetic as indicated by
other investigators [15]. Nonetheless, our data did indicate that
NO treatment reduced endogenous O2
.2 levels which was
associated with the nitration of tyrosine residues. The decrease
in O2
.2 levels was associated with a decrease in endogenous H2O2
levels. This decrease was observed in a panel of breast cancer cell
lines and was not observed when cells were exposed to heat
inactivated DETA. Thus the attenuation in the endogenous levels
of H2O2 upon exposure to NO was universal and specific to the
actions of NO. The decrease in H2O2 levels could be an effect of
both genomic and non genomic actions of NO. The non genomic
action could be due to a decrease in the levels of O2
.2 its direct
precursor, or an activation of catalase due to an attenuation of its
inhibition by O2
.2 as reported earlier [2]. The genomic action
could be attributed to the signaling events connecting activation of
PP2A , dephosphorylation of FOXO1 and subsequent transcrip-
tion of catalase.
We have previously demonstrated a direct correlation of PP2A
activation with the reduction in the basal levels of H2O2 in HBC
cells [2]. In this study we observed the activation of PP2A in at
least two breast cancer cell lines, [MCF7 and MDA-MB-468]
following NO treatment. Therefore, NO mediated reduction in
H2O2 levels and associated activation of PP2A further underlines
the inverse correlation between the activation of PP2A and
[H2O2] in HBC cells. Interestingly we have observed that tissues
from breast tumors exhibited decreased PP2A activity compared
to their normal counter parts. This could have resulted from
inactivation of the thiols of the PP2A active site by elevated H2O2
levels observed in cancer cells. Thiol oxidation by H2O2 at the
active site of phosphatases, have been described in several reports
[16]. Thus reduced levels of H2O2 would shift the equilibrium
towards more active phosphatases as reported earlier [16].
FOXO1 has been reported to be a pro-apoptotic transcription
factor which when activated by dephosphorylation at serine 256
has been shown to transcribe pro-apoptotic genes including BAX
and BAD [17]. Our results further indicated that PP2A caused
FOXO1 activation, as PP2A silenced cells failed to exhibit the
dephosphorylation of pFOXO1 following NO treatment. This
indicated that NO activated FOXO1 via PP2A. FOXO1 induces
the transcription of antioxidant genes such as catalase and
superoxide dismutase along with pro-apoptotic molecules as
mentioned earlier [17]. Increased accumulation of FOXO1 in
the nuclear fraction following DETA treatment further indicated
the important role of FOXO1 in the transcriptional regulation
catalase. Our data indicated that FOXO1 silencing attenuated
mRNA expression of catalase upon treatment with NO. The same
effect on catalase mRNA was observed following silencing of PP2A
thereby indicating that the PP2A-FOXO1 mechanistic axis was
important in the induction of catalase following treatment with
NO. Conversely, overexpression of catalase caused the dephos-
phorylation of pFOXO1 in scrambled controls but not in MDA-
MB-468 cells silenced for PP2A, indicating the operation of a feed
forward activation loop in NO mediated apoptosis.
The major events in the mechanism of NO induced apoptosis
such as activation of catalase, PP2A and dephosphorylation of
phosphorylated FOXO1 were also observed in MCF7 breast
cancer cells. In summary, this study provides data that can be
exploited therapeutically, in that estrogen coupled with NO
donors could be targeted to the breast tissue. Subsequently the NO
released, would induce apoptosis specifically in the transformed
cells which are known to produce increased levels of ROS. NO
would interact with the endogenous ROS to induce apoptosis as
suggested by this work.
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